World News

Gilead Sciences - Women's History Month Celebrated With Its Team

3BL | Sat, Mar 15 2025 12:25 AM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. 

Originally published by Gilead Sciences.

Stock Market

Alibaba launches revamped AI assistant Quark with advanced features

Investing.com -- Alibaba Group Holdings Ltd ADR (NYSE:BABA) has unveiled an updated version of its artificial intelligence (AI) ...

Investing | Sat, Mar 15 2025 03:05 AM AEDT

Read More
World News

Chemours Joins Forces With NTT DATA and Hibiya Engineering, Ltd. for Full-Scale Opteon™ 2P50 Product Trial

Originally published by ChemoursChemours, a global leader in delivering innovative performance chemistry, today announced the launch of a full-scale product ...

3BL | Sat, Mar 15 2025 03:00 AM AEDT

Read More
Stock Market

Bearish sentiment among retail investors hits new milestone amid tariff worries

Investing.com -- The just-released American Association of Individual Investors (AAII) Sentiment Survey revealed a rise in pessimism among individual ...

Investing | Sat, Mar 15 2025 02:21 AM AEDT

Read More
Stock Market

Revolve Group pullback 'offers compelling entry point': Jefferies

Investing.com -- Jefferies raised Revolve Group (NYSE:RVLV) to Buy from Hold on Friday, telling investors in a note ...

Investing | Sat, Mar 15 2025 02:19 AM AEDT

Read More
Market Updates

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

UroShield Cited as Effective in Preventing CAUTIs and Blockages, Having a Major Impact on Quality of Life and Reducing Healthcare ...

Business Wire | Sat, Mar 15 2025 02:00 AM AEDT

Read More